FIBLX | RILGX | FIBLX / RILGX | |
Total Expense Ratio | 0.39 | 1.10 | 35% |
Annual Report Gross Expense Ratio | 0.39 | 1.10 | 35% |
Fund Existence | 5 years | 10 years | - |
Gain YTD | 4.730 | 4.396 | 108% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 13.6B | 13.6B | 100% |
Annual Yield % from dividends | 2.13 | 1.38 | 154% |
Returns for 1 year | 5.99 | 5.30 | 113% |
Returns for 3 years | 4.12 | 1.97 | 210% |
Returns for 5 years | N/A | -0.87 | - |
Returns for 10 years | N/A | 16.52 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MECVX | 15.47 | 0.09 | +0.59% |
NYLI Epoch Capital Growth Investor Class | |||
HSMNX | 36.94 | 0.14 | +0.38% |
Horizon Multi-Factor Small/Mid Cap Inv | |||
FCSDX | 17.25 | 0.04 | +0.23% |
Fidelity Advisor Strategic Div & Inc C | |||
RRSVX | 14.66 | 0.03 | +0.21% |
RBC Small Cap Value R6 | |||
PHSZX | 41.17 | -0.22 | -0.53% |
PGIM Jennison Health Sciences Z |